| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | -38,856 | -10,294 |
| Net increase in cash and cash equivalents | 110,119 | -5,208 |
| Cash and cash equivalents at beginning of period | 229,940 | - |
| Cash and cash equivalents at end of period | 340,059 | - |
Pediatrix Medical Group, Inc. (MD)
Pediatrix Medical Group, Inc. (MD)